Salute e Benessere

EVERSANA Expands Global Commercialisation Capabilities and Strengthens Agency…

"Today's announcement is the next remarkable step in our journey to reinvent commercialisation by effectively integrating what we believe to be the best service providers around the world," said Jim Lang, CEO, EVERSANA. "Gone are the days of siloed, ineffective operations or regional strategies. Our clients need global strategy and integrated commercial services balanced with the right in-market expertise. And now with an even stronger global agency powerhouse connected to…
PR Newswire
11/10/2023

KHB Becomes First Chinese Company to Obtain EU Class D IVDR Certification for…

Early in 2016, KHB's Diagnostic Kit for HIV (1/2) Antibody (Colloidal Gold) V2 was granted WHO Prequalification, demonstrating the company's capability to provide reliable diagnostic products. Since then, KHB has forged extensive and diverse partnerships with leading NGOs such as the WHO, Clinton Health Access Initiative, UNICEF, UNFPA, USAID, The Global Fund, PFSCM and IDA Foundation, across multiple countries and regions. KHB's Diagnostic Kit for HIV (1/2) Antibody (Colloidal Gold) V2 is…
PR Newswire
11/10/2023

Metal Cutting Tool Market to Reach $107.3 Billion, Globally, by 2032 at 4.1%…

Metal cutting tools are a type of tool or device designed to cut or shape various types of metal materials. They can be used in a range of applications, from handheld tools such as hacksaws and snips to more powerful machines like plasma cutters, lasers, and CNC machines. These tools are utilized in a variety of industries, from manufacturing to construction to automotive, and are essential for creating precise and accurate cuts in metal, allowing for the formation of complex designs and…
PR Newswire
11/10/2023

Biocomposites announces new territories approved to promote STIMULAN as an…

KEELE, England, Oct. 11, 2023 /PRNewswire/ -- Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is pleased to announce that Argentina and Taiwan are the latest territories to approve STIMULAN® as an antibiotic carrier that can be used in bone and soft tissue. They join a rapidly expanding list of territories which already includes UK, EU, Canada, Saudi Arabia, Mexico and…
PR Newswire
11/10/2023

SKF to publish nine-months results on 27 October

To join the webcast, please login at least 10 minutes before the start using the below link or phone numbers. To join the webcast, please login at least 10 minutes before the start using the below link or phone numbers. Link to web event:https://www.investis-live.com/skf/6511567e673c270c00dcf364/hsdt Sweden +46 8 5051 0031 UK / International +44 207 107 0613Passcode: 42753649 All information regarding the...
PR Newswire
11/10/2023

Orexo announces data from the MODIA® study evaluating impact on use of illicit…

The study was a randomized, open-label, parallel-group study, enrolling patients aged 18 to 65 across the US who voluntarily sought treatment for documented moderate to severe OUD. Participants were inducted and stabilized on buprenorphine/naloxone during a brief screening period, then evaluated during weekly visits over the course of 24 weeks, with a primary endpoint defined as the subject having ≥80 percent of urine drug tests negative for illicit opioids and negative self-reports for illicit…
PR Newswire
11/10/2023

MinervaX Raises EUR 54M in Upsized Financing to Advance the Development of its…

The Company is currently progressing two Phase II clinical trials in 470 pregnant persons across Denmark, United Kingdom, Uganda and South Africa. Initial data from these clinical trials are highly positive and demonstrate that the vaccine has an acceptable safety profile, is highly immunogenic and gives rise to functionally active antibodies. Details of MinervaX's clinical trials can be found at clinicaltrials.gov under the identifiers NCT04596878 and NCT05154578. In addition to pregnant…
PR Newswire
11/10/2023

InDex Pharmaceuticals announces that all patients needed for the cobitolimod…

Phase III program Phase III program Induction Study 1 will include approximately 440 patients and is conducted at several hundred clinics in 30 countries inEurope, the Americas and theAsia-Pacificregion. The CONCLUDE program consists of two sequential induction studies which both feed into a maintenance study with patients who have responded to induction therapy. Each patient remains in the maintenance study for approximately one year. Dose selection analysis With 30% of...
PR Newswire
11/10/2023

AMBU APPOINTS NEW CHIEF FINANCIAL OFFICER

Thomas Frederik Schmidt will step down as CFO of Ambu by 31 December 2023; Henrik Skak Bender named as new CFO, effective 1 January 2024. Ambu A/S has appointed Henrik Skak Bender as the company's new Chief Financial Officer and member of the Executive Management, effective 1 January 2024. Henrik succeeds Thomas Frederik Schmidt, who will step down, effective 31 December 2023.During Thomas' period as CFO, the financial situation of Ambu has stabilised, the company has returned to...
Nasdaq GlobeNewswire
11/10/2023

Print on Demand Market to Reach $64.3 Billion, by 2032 at 26.4% CAGR: Allied…

The print on demand (PoD) business model enables individuals and businesses to create personalized products without the need for storing inventory or owning production facilities. With PoD solutions and services, sellers upload their designs to online platforms, customers place orders for products featuring these designs, and the PoD providers take care of production, packaging, and direct shipping to the customers. This approach offers several advantages, including lower initial expenses…
PR Newswire
11/10/2023

Smith+Nephew opens new state-of-the-art surgical innovation and training centre…

S+N Academy Munich is the latest addition to a global network of nine Academies, across three continents. At its peak, S+N Academy Munich is expected to train up to 5,000 global healthcare providers at the site each year. S+N Academy Munich is the latest addition to a global network of nine Academies, across three continents. At its peak, S+N Academy Munich is expected to train up to 5,000 global healthcare providers at the site each year. Additionally, S+N Academy Munich…
PR Newswire
11/10/2023

Roche's OCREVUS twice-yearly, 10-minute subcutaneous injection was non-inferior…

Late-breaking Phase III results show subcutaneous injection was non-inferior to intravenous infusion based on OCREVUS levels in the blood over 12 weeks OCREVUS subcutaneous injection was comparable to IV infusion in providing rapid and sustained depletion of B cells and near-complete suppression of MRI lesion activity in the brain over 24 weeksThe safety profile of OCREVUS subcutaneous injection was consistent with the well-established safety profile of OCREVUS IV infusionThe...
Nasdaq GlobeNewswire
11/10/2023

Shareholder Letter

Dear Shareholders, We write to you today with a deep sense of responsibility and transparency, driven by our commitment to the principles of sound corporate governance and the long-term success of Mithra. We believe it is our duty to address recent developments concerning the request of some shareholders for the upcoming Special General Meeting of Shareholders ("SGM") to be held on October 30, 2023. The SGM will be followed by an Extraordinary Meeting of Shareholders ("EGM")…
Nasdaq GlobeNewswire
11/10/2023

Mithra announces update to the agenda of its upcoming special general…

Liege, Belgium, 11 October 2023 – 7:00 CEST– Mithra (Euronext Brussels: MITRA) (the "Company"), a company dedicated to Women's Health, today announces that it has received a request, in accordance with article 7:130 of the Belgian Companies and Associations Code, from a group of shareholders holding together more than 3% of the Company's outstanding shares to add additional items and resolutions to the agenda of its special general shareholders' meeting ("SGM") that will…
Nasdaq GlobeNewswire
11/10/2023

EQT to acquire VetPartners, the leading provider of veterinary and animal health…

Drawing on its global experience in the animal health sector, via this standalone investment EQT will support VetPartners' medical professionals to continue to deliver the highest-quality clinical outcomes to the animals entrusted to their care. EQT is committed to invest significantly to ensure VetPartners' clinical teams have access to the latest medical equipment, digital tools and innovation capabilities. EQT also intends to provide significant investment to further VetPartners' mission to…
PR Newswire
11/10/2023

Xinhua Silk Road: Report on global fashion vitality index released to empower…

The report points out that it is necessary to give full play to the important role of global fashion events in innovating consumption scenes and stimulating consumption vitality in a bid to inject new momentum into the construction of international consumption center cities. The report points out that it is necessary to give full play to the important role of global fashion events in innovating consumption scenes and stimulating consumption vitality in a bid to inject new momentum into the...
PR Newswire
11/10/2023

A Comprehensive Analysis of the Chemotherapy-induced Complications Market…

Chemotherapy has undeniably been a pivotal tool in the treatment of cancer, but it comes with its share of complications. The severity and type of side effects can vary depending on the specific drugs used, the duration of treatment, and individual patient factors. To mitigate these complications, oncologists carefully select chemotherapy regimens and often combine them with other treatments to maximize effectiveness while minimizing side effects. Chemotherapy has undeniably been a pivotal…
PR Newswire
10/10/2023

Novo Nordisk will stop the once-weekly injectable semaglutide kidney outcomes…

Novo Nordisk will stop the once-weekly injectable semaglutide kidney outcomes trial, FLOW, based on interim analysis Bagsværd, Denmark, 10 October 2023– Novo Nordisk today announced the decision to stop the kidney outcomes trial FLOW (Effect of semaglutide versus placebo on the progression of renal impairment in people with type 2 diabetes and chronic kidney disease).The decision to stop the trial is based on a recommendation from the independent Data Monitoring Committee (DMC)...
Nasdaq GlobeNewswire
10/10/2023

The Cosmeceuticals Market to Worth $120.31 Billion by 2028, Nano-Cosmeceuticals…

Browse in-depth TOC on Cosmeceuticals Market Browse in-depth TOC on Cosmeceuticals Market 143 – Tables 127 – Figures 299 – Pages Cosmeceuticals Market Report Scope · Increasing Awareness & Expenditure for Personal Care The beauty industry is experiencing significant growth due to emerging trends and a growing emphasis on personal care worldwide. A substantial portion of the global population invests heavily in beauty, personal care items, cosmeceuticals,...
PR Newswire
10/10/2023

Holter Monitor Market to Reach $1.20 Billion by 2029, 3-Channel Type Monitors…

The report analyses the current state of the global Holter monitor market and its market dynamics from 2024 to 2029. It provides an extensive overview of various factors that drive growth, hinder growth, and highlight trends within the market. This study encompasses both the aspects of demand and supply within the industry. Furthermore, it offers profiles and assessments of top companies and other noteworthy firms operating in this sector. The report analyses the current state of the global...
PR Newswire
10/10/2023

The Global Contact Lenses Market to Worth $13.57 Billion by 2029, Growing…

Contact Lenses Market Report Scope Contact Lenses Market Report Scope The US has emerged as the largest market for contact lenses due to seamless retail distribution networks and online sales expansion in the country. The country's high penetration rate of contact lenses is attributable to a significant population of early adopters. Also, all these factors have increased the revenue of vendors operating in the market. The use of cosmetic contact lenses is comparatively high in the US...
PR Newswire
10/10/2023

Information on the Total Number of Voting Rights (Denominator) following…

Regulated Information - Denominator Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and differentiated back of the eye drug candidate targeting potential market opportunities of over USD 5 billion.Leuven, BELGIUM, Boston, MA, US – October 10, 2023 – 08.00 PM CET– In...
Nasdaq GlobeNewswire
10/10/2023

Mallinckrodt plc (in examinership) Receives U.S. Court Approval for Financial…

Mallinckrodt's Plan of Reorganization is supported by a substantial majority of its financial stakeholders, including holders of approximately 90% of its first and second lien debt and the Opioid Master Disbursement Trust II (the "Trust"), as part of a previously announced Restructuring Support Agreement. Upon emergence, Mallinckrodt will eliminate approximately $1.9 billion of total funded debt and ownership of the business will transition to the Company's creditors. In addition, the…
PR Newswire
10/10/2023

EssilorLuxottica: Third-Quarter 2023 Revenue Conference Call Invitation

Third-Quarter 2023 Revenue Conference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, and Mr GIORGIO IANNELLA, Head of Investor Relations,have the pleasure of inviting you to our Third-Quarter 2023 Revenue Conference Call on: Thursday, October 19, 2023, at 6:30 pm CEST Dial-in telephone access:If you wish to dial into the conference call, please pre-register at the following link to receive the personal credentials (Dial-in numbers, Conference ID and User ID):...
Nasdaq GlobeNewswire
10/10/2023
Altri  Comunicati